Immune checkpoint blockers (ICBs) targeting programmed death receptor 1 (PD-1) ligand 1
(PD-L1) for immunotherapy have radically reformed oncology. It is of great significance to …

Two types of antibody-labeled nanoparticles (mAb-NPs) were prepared with the aim to
achieve specific tumor targeting. Anti-HER2 and anti-CD20 monoclonal antibodies (mAb) …

Cancer is one of the major causes of human death. There are many types of cancer
treatment including surgery, chemotherapy, radiotherapy, and photothermal therapy …

Paclitaxel (Tx)-loaded anti-HER2 immunonanoparticles (NPs-Tx-HER) were prepared by the
covalent coupling of humanized monoclonal anti-HER2 antibodies (trastuzumab …

Purpose The rationale of the present study was to radiolabel rituximab with 99m-technetium
and to image B lymphocytes infiltration in the affected tissues of patients with chronic …

Purpose. To evaluate the feasibility of regional radiochemotherapy of mammary tumors
using in situ hydrogel loaded with cisplatin (CDDP) and rhenium-188 (188 Re). Methods …

Trastuzumab that targets the human epidermal growth factor receptor type 2 (HER2) is
known to benefit patients with HER2+ metastatic breast cancer. The objective was to explore …

The anti-EGFR antibody Nimotuzumab was radioiodinated with I-131 by Chloramine T and
Iodogen methods. The 131 I-Nimotuzumab was purified and characterized by HPLC …

We present the long-term results of 18 chemotherapy relapsed indolent (N= 12) or
transformed (N= 6) NHL patients of a phase II anti-CD20 131 I-tositumomab (Bexxar®) …

Purpose The humanized monoclonal antibody hR3, both alone and in combination with
other chemotherapeutic agents and radiotherapy, can be used to treat head and neck …